CD274 and neoplasm: Biomarkers, including PD-1, PD-L1, CTC, and TMB, have limited predictive accuracy due to the unavailability of tumor tissue and molecular or microscopic analyses (Lianidou et al., 2015; Yi et al., 2018; Ritterhouse, 2019).